Research Forensic Library

A program of the Global Forensic and Justice Center at Florida International University

Drug Enforcement Administration

TitleSourceLinkYear
Schedules of Controlled Substances: Placement of Brorphine in Schedule IDEA; March 6, 2023www.federalregister.gov/documents/2023/03/06/2023-04364/schedules-of-controlled-substances-placement-of-brorphine-in-schedule-i2023
DEA Tox – Quarterly Report – 4th QuarterDEA; 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule IDEA; December 23, 2022www.federalregister.gov/documents/2022/12/23/2022-27278/schedules-of-controlled-substances-temporary-placement-of-etizolam-flualprazolam-clonazolam2022
Summary of Validated Quantitative MethodsDEA; 40pp; December 2022www.dea.gov/documents/2022/2022-12/2022-12-07/summary-validated-quantitative-methods2022
Summary of Validated Qualitative MethodsDEA; 106pp; December 2022www.dea.gov/documents/2022/2022-12/2022-12-07/summary-validated-qualitative-methods2022
Drugs of Abuse – A DEA Resource Guide – 2022 EditionDEA; 115pp; 2022www.dea.gov/documents/2022/2022-12/2022-12-02/drugs-abuse-20222022
DEA Tox – Toxicology Testing ProgramDEA; Third Quarter; 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
Schedules of Controlled Substances: Placement of Mesocarb in Schedule IDEA; November 22, 2022www.federalregister.gov/documents/2022/11/22/2022-25219/schedules-of-controlled-substances-placement-of-mesocarb-in-schedule-i2022
Schedules of Controlled Substances: Placement of Zipeprol in Schedule IDEA; November 21, 2022www.federalregister.gov/documents/2022/11/21/2022-25206/schedules-of-controlled-substances-placement-of-zipeprol-in-schedule-i2022
Schedules of Controlled Substances: Placement of Amineptine in Schedule IDEA; November 17, 2022www.federalregister.gov/documents/2022/11/17/2022-25003/schedules-of-controlled-substances-placement-of-amineptine-in-schedule-i2022
Schedules of Controlled Substances: Placement of Daridorexant in Schedule IVDEA; September 30, 2022www.federalregister.gov/documents/2022/09/30/2022-21253/schedules-of-controlled-substances-placement-of-daridorexant-in-schedule-iv2022
NFLIS-Drug SnapshotDEA; June 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2021
DEA Tox – Quarterly Report – 2nd QuarterDEA; August 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IVDEA; June 24, 2022www.federalregister.gov/documents/2022/06/24/2022-13538/schedules-of-controlled-substances-placement-of-serdexmethylphenidate-in-schedule-iv2022
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule I\DrugDEA; June 6, 2022www.federalregister.gov/documents/2022/06/06/2022-11933/schedules-of-controlled-substances-placement-of-methoxetamine-mxe-in-schedule-i2022
Schedules of Controlled Substances: Placement of N-Ethylhexedrone, alpha-Pyrrolidinohexanophenone, 4-Methyl-alpha-ethylaminopentiophenone, 4′-Methyl-alpha-pyrrolidinohexiophenone, alpha-Pyrrolidinoheptaphenone, and 4′-Chloro-alpha-pyrrolidinovalerophenone in Schedule IDEA; June 1, 2022www.federalregister.gov/documents/2022/06/01/2022-11740/schedules-of-controlled-substances-placement-of-n-ethylhexedrone-alpha-pyrrolidinohexanophenone2022
Schedules of Controlled Substances: Placement of Ganaxolone in Schedule VDEA; June 1www.federalregister.gov/documents/2022/06/01/2022-11735/schedules-of-controlled-substances-placement-of-ganaxolone-in-schedule-v2022
DEA TOX: Quarterly Report – 1st Quarter 2022DEA; May 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
NFLIS-Drug 2021 midyear reportDEA; 32pp; April 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2022
Synth-Opioids Real-Time Communication Network – 2021 annual reportNFLIS; April 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2022
Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule IDEA; April 11, 2022www.federalregister.gov/documents/2022/04/11/2022-07648/schedules-of-controlled-substances-placement-of-25-dimethoxy-4-iodoamphetamine-doi-and2022
Schedules of Controlled Substances: Placement of 5F-EDMB-PINACA, 5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in Schedule I; Final ruleDEA; April 7, 2022www.federalregister.gov/documents/2022/04/07/2022-07320/schedules-of-controlled-substances-placement-of-5f-edmb-pinaca-5f-mdmb-pica-fub-akb482022
DEA TOX: Quarterly Report – 4th Quarter 2021DEA; 2022www.deadiversion.usdoj.gov/dea_tox/index.html2022
NFLIS-Drug Special Report: Gabapentin and Pregabalin Reported in NFLIS, 2011–2020DEA; 2022www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2022
Emoji Drug Code DecodedDrug Enforcement Administration; January 2022www.dea.gov/sites/default/files/2021-12/Emoji%20Decoded.pdf2022
Schedules of Controlled Substances: Placement of Methoxetamine (MXE) in Schedule IDrug Enforcement Administration; December 7, 2021www.federalregister.gov/documents/2021/12/07/2021-26293/schedules-of-controlled-substances-placement-of-methoxetamine-mxe-in-schedule-i2021
Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule IDrug Enforcement Administration; December 7, 2021www.federalregister.gov/documents/2021/12/07/2021-26263/schedules-of-controlled-substances-temporary-placement-of-butonitazene-etodesnitazene-flunitazene2021
Designation of Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I ChemicalDocument Number 2021-24952, 86 FR 64362, pp 64362-64366, November 18, 2021www.federalregister.gov/documents/2021/11/18/2021-24952/designation-of-methyl-alpha-phenylacetoacetate-a-precursor-chemical-used-in-the-illicit-manufacture2021
NFLIS-Drug 2020 Annual ReportNFLIS; 36pp; 2021www.nflis.deadiversion.usdoj.gov/publicationsRedesign.xhtml2021
Emerging Threat Report; Mid-Year 2021Drug Enforcement Administration; October 2021forensiclibrary.org/archives/6835#2021
Schedules of Controlled Substances: Placement of Isotonitazene in Schedule IDEA; November 4www.federalregister.gov/documents/2021/11/04/2021-23848/schedules-of-controlled-substances-placement-of-isotonitazene-in-schedule-i2021
Schedules of Controlled Substances: Placement of Methiopropamine in Schedule IDepartment of Justice; September 2, 2021downloads.regulations.gov/DEA_FRDOC_0001-0381/content.pdf2021
Laboratory Operations ManualDEA; 269 pages; 2021www.dea.gov/documents/2019/2019-11/2019-11-15/laboratory-operations-manual2021
Schedules of Controlled Substances: Placement of Mesocarb in Schedule IDrug Enforcement Administration; Department of Justice; August 11, 2021www.govinfo.gov/content/pkg/FR-2021-08-11/pdf/2021-16489.pdf2021
Global Forensic and Justice Center

11200 SW 8th Street
Miami, FL 33199
Contact Us